An open-label, parallel, multiple-dose study comparing the pharmacokinetics and gastric acid suppression of rabeprazole extended-release with esomeprazole 40 mg and rabeprazole delayed-release 20 mg in healthy volunteers.
Phase of Trial: Phase II
Latest Information Update: 29 Mar 2011
At a glance
- Drugs Esomeprazole; Rabeprazole
- Indications Gastro-oesophageal reflux; Peptic ulcer
- Focus Pharmacodynamics; Pharmacokinetics
- 29 Mar 2011 New trial record